Drug intelligence / Profile preview

20% PEP

Development stage
Unknown
Lead developer
Mayo Clinic
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical
01

Overview

20% PEP is a 20% concentration formulation of Purified Exosome Product (PEP), an investigational cell-free regenerative biologic developed by Rion in collaboration with the Mayo Clinic. Formulated as a shelf-stable lyophilized powder derived from human platelets, PEP contains stabilized regenerative exosomes that deliver polyvalent biological signals to recipient cells. It is designed to promote cell proliferation, migration, and angiogenesis while reducing inflammation and protecting cells. The 20% concentration formulation has been evaluated in a Phase 1b clinical trial for the treatment of split-thickness skin graft donor site wounds, and the broader PEP platform is under investigation for various indications including diabetic foot ulcers, knee osteoarthritis, musculoskeletal injuries, and pulmonary diseases.

Other names
20% PEP™20% Purified Exosome Product20% Purified Exosome Product™

Beyond the preview

Go deeper on 20% PEP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 20% PEP.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call